| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CITIUS ONCOLOGY, INC. | Director | Common Stock | 300K | $363K | $1.21 | 19 Sep 2025 | Direct |
| CITIUS ONCOLOGY, INC. | Director | Stock Option (Right to Buy) | 125K | $261K | $2.09 | 19 Sep 2025 | Direct |
| Citius Pharmaceuticals, Inc. | Director | Stock Option (Right to Purchase Common Stock) | 125K | 07 Nov 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CTOR | CITIUS ONCOLOGY, INC. | 19 Sep 2025 | 1 | $0 | 4/A | Director | 22 Dec 2025, 16:10 |
| CTOR | CITIUS ONCOLOGY, INC. | 19 Sep 2025 | 1 | $0 | 4/A | Director | 01 Dec 2025, 16:10 |
| CTOR | CITIUS ONCOLOGY, INC. | 12 Dec 2024 | 1 | $0 | 4 | Director | 16 Dec 2024, 16:08 |
| CTXR | Citius Pharmaceuticals, Inc. | 07 Nov 2024 | 1 | $0 | 4 | Director | 12 Nov 2024, 17:00 |
| CTOR | CITIUS ONCOLOGY, INC. | 12 Aug 2024 | 0 | $0 | 3 | Director | 14 Aug 2024, 18:23 |
| CTXR | Citius Pharmaceuticals, Inc. | 14 Mar 2024 | 1 | $0 | 4 | Director | 18 Mar 2024, 16:06 |
| CTXR | Citius Pharmaceuticals, Inc. | 12 Mar 2024 | 0 | $0 | 3 | Director | 18 Mar 2024, 16:05 |